Guided Therapeutics (GTHP) Debt to Equity (2011 - 2025)
Guided Therapeutics' (GTHP) quarterly Debt to Equity came in at -$0.01 in Q4 2025, up 70.37% year-on-year from -$0.01 in Q4 2024, and up 47.22% quarter-over-quarter from -$0.02 in Q3 2025.
Guided Therapeutics (GTHP) Debt to Equity (2011 - 2025) Analysis & Trends
Guided Therapeutics has disclosed Debt to Equity across 14 years of filings, most recently posting -$0.01 for Q4 2025.
- Debt to Equity for Q4 2025 came in at -$0.01, up 70.37% year-over-year; the trailing twelve-month figure through Dec 2025 was -$0.01 (up 70.37% YoY), and the FY2025 annual result was -$0.01, up 70.37% from the prior year.
- Debt to Equity came in at -$0.01 for Q4 2025 at Guided Therapeutics, up from -$0.02 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of -$0.01 in Q1 2021 to a low of -$0.25 in Q2 2024.
- The 4-year median for Debt to Equity is -$0.02 (2022), against an average of -$0.07.
- Across the five-year window, Debt to Equity plunged 3545.45% in 2021 and soared 93.19% in 2025, its largest moves.
- Guided Therapeutics' Debt to Equity stood at -$0.02 in 2021, then slumped by 71.7% to -$0.03 in 2022, then grew by 2.7% to -$0.03 in 2024, then jumped by 70.37% to -$0.01 in 2025.
- The last three Debt to Equity figures came in at -$0.01 (Q4 2025), -$0.02 (Q3 2025), and -$0.02 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.71 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 0.27 |
| 10 | Guided Therapeutics | - | - | 458,000.00 | -0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.01 |
| Sep 30, 2025 | -0.02 |
| Jun 30, 2025 | -0.02 |
| Mar 31, 2025 | -0.02 |
| Dec 31, 2024 | -0.03 |
| Sep 30, 2024 | -0.24 |
| Jun 30, 2024 | -0.25 |
| Dec 31, 2022 | -0.03 |
| Sep 30, 2022 | -0.01 |
| Jun 30, 2022 | -0.02 |
| Mar 31, 2022 | -0.12 |
| Dec 31, 2021 | -0.02 |
| Sep 30, 2021 | -0.08 |
| Jun 30, 2021 | -0.11 |
| Mar 31, 2021 | -0.01 |
| Dec 31, 2020 | -0.03 |
| Sep 30, 2020 | -0.04 |
| Jun 30, 2020 | 0.00 |
| Mar 31, 2020 | -0.05 |
| Dec 31, 2019 | -0.03 |